Brensocatib

Metabolites - Brensocatib is an oral anti-inflammatory drug that inhibits the enzyme dipeptidyl peptidase-1 (DPP-1). An oral medication for a chronic lung disease called non-cystic fibrosis bronchiectasis (NCFB) that works by reducing inflammation to prevent flare-ups and lung damage. Reference standards of Brensocatib API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

No Data Found